Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
If the layoff rate remains constant, one could expect 252 workforce reductions by the end of the year—a 27% percentage point jump from 2024.
Gabrielle Masson
Oct 3, 2025 4:30pm
Merck opts in on Evaxian's preclinical vaccine candidate
Sep 25, 2025 7:00am
Fierce Pharma
RFK Jr.'s ACIP delivers perplexing vote on MMRV vaccine guidance
Sep 18, 2025 6:33pm
Fierce Pharma
RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation
Sep 4, 2025 3:51pm
Pfizer, Valneva boosted by updated Lyme vaccine data
Sep 3, 2025 10:19am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am